1King DK,Mainous AG 3rd,Egan BM,et al. Use of Statins and Blood Pressure[J]. Am J Hypertens, 2007,20(9) : 937-941.
2Strazzullo P, Kerry SM, Barbato A, et al. Do statins reduce blood pressure? a meta-analysis of randomized controlled trials [J]. Hypertension,2007,49(4) :792-798.
3Glorioso N,Troffa C,Filigheddu F,et al. Effect of the HMG- CoA reductase inhihitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia[J]. Hypertension, 1999,34(6) : 1281-1286.
4Borghi C, Prandin MG, Costa FV, et al. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia [J]. J Cardiovasc Pharmacol, 2000, 35 (4):549-555.
5Sposito AC,Mansur AP,Coelho OR,et al. Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril) [J]. Am J Cardiol, 1999,83 (10) : 1497- 1499.
6Ikeda T, Sakurai J, Nakayama D, et al. Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs[J]. Am J Hypertens, 2004,17(6):502-506.
7Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J]. Hypertension, 2001,37(6) : 1450-1457.
8Dinko Susie MD, PhD, Jasmina Varagie MD, PhD, Jwari Ahn MD,et al. Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models [J]. J Am Coll Cardiol, 2003,42 (6) : 1091-1097.
9Laufs U,Gertz K,Dirnagl U,et al. Rosuvastatin,a new HMG- CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice[J]. Brain Res,2002,942(1/2):23-30.
4Solymoss BC, Marcil M, Chaour M, et al. Fasting hyperinsulinism, insulin resistance syndrone, and coronary artery disease in men and women. Am J Cardiol, 1995; 76(16):1152.
5Maria Pyorala, Hiettinen H, Laakso M, et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men.(The 22-years follow-up results of the helsinki policemen study). Circulation, 1998; 98(5):398.
6Goldberg R, Sacks F, Howard B, et al. Diabetic response to pravastatin during the CARE study. Circulation, 1996; 94(suppl I) :1.
7Horio T, Kohno M, Murakawa K, et al. Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats. Atherosclerosis, 1991 ; 89 : 239.
8Quyyumi AA, Mulcahy D, Andrews NP, et al. Coronary vascular nitric oxide activity in hypertention and hyperrcholesterolemia. Circulation, 1997; 95(1):104.
9Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins implications for cardiovascular event reduction. JAMA,1998; 279(20) ;27.
10Abdelmouttaleb I, Danchin N, Ilaudo C, et aL C-Reactive protein and coronary artery disease; additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J, 1999; 137(2):346.
